Oncology Innovations Fund Lp Mpm serves as Executive at Werewolf Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Oncology Innovations Fund Lp Mpm has executed 3 insider transactions totaling $391.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 3, 2025 involved selling 94,063 shares valued at $121.3K.
Oncology Innovations Fund Lp Mpm currently holds 6,147,610 shares of Werewolf Therapeutics, Inc. (HOWL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Oncology Innovations Fund Lp Mpm has been a net seller of HOWL stock. They have purchased $0 and sold $391.6K worth of shares.
Oncology Innovations Fund Lp Mpm's most recent insider trade was on Nov 3, 2025, when they sold 94,063 shares at $1.29 per share.
Get notified when new Form 4 filings are submitted
| $1.28 |
| Discretionary |
| Oct 30, 2025 | HOWL | $124.3K | Sale | 86,936 | $1.43 | Discretionary |